3rd FDA panel barely favors BSX's Watchman | Regulatory news for the week of October 13, 2014

Here's a look at some of the top regulatory stories for medical device companies this week: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device; Medtronic launches Verify incontinence device in the U.S.; FDA OKs Integra Lifesciences Puerto Rico plant; FDA approves Bard's Lutonix DEB UPDATE: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device October 9, 2014 by Brad Perriello Boston Scientific, C.R. Bard, Food & Drug Administration (FDA), Integra LifeSciences Corp., MedtronicNews Well, Regulatory/Complianceread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news